TY - JOUR
T1 - CAMP-independent effects of cholera toxin on B cell activation
T2 - III. Cholera toxin a subunit-mediated ADP-ribosylation acts synergistically with lonomycin or IL-4 to induce B cell proliferation
AU - Francis, Mark L.
AU - Okazaki, Lan
AU - Moss, Joel
AU - Kurosky, Alexander
AU - Pecanha, Ligia M.T.
AU - Mond, James J.
PY - 1995
Y1 - 1995
N2 - To investigate whether ADP-ribosylation of proteins by cholera toxin could influence B cell activation, B cells were incubated with the A subunit of cholera toxin, lonomycin acted synergistically to induce B cell proliferation with the A subunit of cholera toxin but not with cAMP-enhancing agents or with the B subunit of cholera toxin, suggesting that the synergistic effect of the A subunit was mediated via ADP-ribosylation and not via cAMP elevations or ganglioside GM1 binding. Indeed, inhibitors of ADP-ribosylation blocked the synergistic effect. Unlike anti-lg, B cell proliferation stimulated by LPS or by the combination of the A subunit and ionomycin was observed in protein kinase C (PKC)-depleted B cells. However, neither the A subunit nor ionomycin enhanced B cell proliferation stimulated by low dose LPS, suggesting that the A subunit plus ionomycin stimulated an activation pathway distinct from the LPS-stimulated pathway. Additionally, unlike LPS, the A subunit plus ionomycin did not stimulate B cells in vitro to secrete Ig. IL-4 acted synergistically with the A subunit to induce B cell proliferation to the same extent as it did with anti-lg; unlike the anti-lg plus IL-4 synergy, however, the A subunit plus IL-4mediated synergy persisted in PKC-depleted B cells. Taken together, our data suggest that cholera toxin A subunitcatalyzed ADP-ribosylation modifies a non-Gs protein involved in the activation of B cells, either through a novel pathway or at a point distal to the activation of PKC along the anti-lg-stimulated pathway.
AB - To investigate whether ADP-ribosylation of proteins by cholera toxin could influence B cell activation, B cells were incubated with the A subunit of cholera toxin, lonomycin acted synergistically to induce B cell proliferation with the A subunit of cholera toxin but not with cAMP-enhancing agents or with the B subunit of cholera toxin, suggesting that the synergistic effect of the A subunit was mediated via ADP-ribosylation and not via cAMP elevations or ganglioside GM1 binding. Indeed, inhibitors of ADP-ribosylation blocked the synergistic effect. Unlike anti-lg, B cell proliferation stimulated by LPS or by the combination of the A subunit and ionomycin was observed in protein kinase C (PKC)-depleted B cells. However, neither the A subunit nor ionomycin enhanced B cell proliferation stimulated by low dose LPS, suggesting that the A subunit plus ionomycin stimulated an activation pathway distinct from the LPS-stimulated pathway. Additionally, unlike LPS, the A subunit plus ionomycin did not stimulate B cells in vitro to secrete Ig. IL-4 acted synergistically with the A subunit to induce B cell proliferation to the same extent as it did with anti-lg; unlike the anti-lg plus IL-4 synergy, however, the A subunit plus IL-4mediated synergy persisted in PKC-depleted B cells. Taken together, our data suggest that cholera toxin A subunitcatalyzed ADP-ribosylation modifies a non-Gs protein involved in the activation of B cells, either through a novel pathway or at a point distal to the activation of PKC along the anti-lg-stimulated pathway.
UR - http://www.scopus.com/inward/record.url?scp=0029041926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029041926&partnerID=8YFLogxK
M3 - Article
C2 - 7730606
AN - SCOPUS:0029041926
SN - 0022-1767
VL - 154
SP - 4956
EP - 4964
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -